Extending Healthy Human Lifespan For All

Our mission is to promote biomedical technologies that will increase healthy human lifespan. By crowdfunding research efforts and engaging the public, we aim to more quickly bring about a future free from age-related diseases.

 Extending Healthy Human Lifespan For All

Global population is rapidly aging as fertility declines and life expectancy increases. According to the United Nations Population Prospects, in 2015, 12% of the global population were aged 60 or over. By 2050, this group will make up 22%, while by 2100 old people will constitute about one third of the global population.

The increasing burden of age-related diseases poses an unbearable load on the system of healthcare. The imbalance between a productive workforce and people who become dependent because of age-related disability represents a major challenge for the global economy.

Health is the most important aspect of remaining productive and contributing to socio-economic development. We believe that, by supporting the creation and implementation of new biotechnologies aimed at bringing the aging processes under medical control, we can help millions of people remain healthier for longer, and have happier and more productive lives.

Fostering the Development of Rejuvenation Biotechnology

In 2014, the Life Extension Advocacy Foundation was established as a 501(c)(3) non-profit organization dedicated to promoting healthy human lifespan through fiscally sponsoring longevity research projects and raising awareness regarding the societal benefits of healthy life extension.

In 2015, we launched Lifespan.io, the first nonprofit crowdfunding platform focused on the biomedical research of aging.

We believe that this will enable the general public to influence the pace of research directly. To date, we have successfully supported six research projects aimed at investigating different aging processes and developing therapies to treat age-related diseases.


Maintaining Public Dialogue About Healthy Life Extension

While we live in an era of universal access to information, there is a lack of information available to the public about the processes of aging and the progress in preventing and postponing age-related diseases through emerging medical technologies.

The LEAF team organizes educational events, takes part in different public and scientific conferences, and actively engages with the public on social media in order to help disseminate this crucial information.

We initiate public dialogue aimed at regulatory improvement in the fields related to rejuvenation biotechnology.

We also work to attract more attention from decision makers to the need for increased funding allocation for fundamental and translational gerontology.